TWI835590B - Implant - Google Patents
Implant Download PDFInfo
- Publication number
- TWI835590B TWI835590B TW112109422A TW112109422A TWI835590B TW I835590 B TWI835590 B TW I835590B TW 112109422 A TW112109422 A TW 112109422A TW 112109422 A TW112109422 A TW 112109422A TW I835590 B TWI835590 B TW I835590B
- Authority
- TW
- Taiwan
- Prior art keywords
- cavity
- implant
- cavities
- openings
- opening
- Prior art date
Links
Landscapes
- Prostheses (AREA)
Abstract
本創作提出一種植體,其具有一外表面及複數個空腔。外表面形成有複數個開口,而空腔分別連通於該等開口。具體而言,體為血管支架,其具有多個條狀結構及形成於條狀結構的多個管體。前述開口及空腔形成於管體上。空腔的最大橫向截面的面積大於該等開口的截面積,該橫向截面平行於該外表面。因此,本創作的優點在於,植體的表面形成有許多連通於空腔的開口,因此在植體表面上塗敷藥劑時,藥劑可流入空腔內。由於空腔的最大橫向截面大於開口,因此藥劑可流入空腔後不易由開口流出,而能吸附更多的藥劑。This invention proposes an implant, which has an outer surface and a plurality of cavities. A plurality of openings are formed on the outer surface, and the cavities are respectively connected to the openings. Specifically, the body is a vascular stent, which has multiple strip structures and multiple tube bodies formed in the strip structures. The aforementioned openings and cavities are formed on the tube body. The area of the largest transverse section of the cavity is greater than the cross-sectional area of the openings, the transverse section being parallel to the outer surface. Therefore, the advantage of this invention is that the surface of the implant is formed with many openings connected to the cavity, so when the medicine is applied on the surface of the implant, the medicine can flow into the cavity. Since the maximum transverse cross-section of the cavity is larger than the opening, the medicament can flow into the cavity and not easily flow out through the opening, and more medicament can be adsorbed.
Description
本創作是關於一種植入人體的植體,特別是該植體的表面結構。This creation is about an implant implanted in the human body, especially the surface structure of the implant.
許多手術都會將人工製造物植入人體,這些人工製造物即為俗稱的植體。常見的植體是植牙手術的人工牙根,或是心導管手術的血管支架。人工牙根植體是穿入牙床,因此牙床的骨頭是會預先鑽出一個小洞來讓人工牙根插入並固定。一段時間後牙床的骨頭會增生,因此能使人工牙根穩固地被固定在牙床上。然而,骨頭增生的速度非常緩慢,因此患者在術後有諸多不便。如何提升骨頭增生的速度,便成為植牙手術的一大課題。相反地,血管支架植體手術後,若血管增生,則血管容易再次堵塞,因此如何降低再阻塞率,也是血管支架手術的一大課題。Many surgeries involve the implantation of artificial objects into the human body. These artificial objects are commonly known as implants. Common implants are artificial tooth roots for dental implant surgery or vascular stents for cardiac catheterization surgery. Artificial tooth root implants are inserted into the gums, so a small hole is pre-drilled in the bone of the gums for the artificial tooth roots to be inserted and fixed. Over time, the bone in the gums will grow, allowing the artificial tooth roots to be firmly fixed on the gums. However, the rate of bone growth is very slow, so patients have a lot of inconvenience after surgery. How to increase the speed of bone proliferation has become a major issue in dental implant surgery. On the contrary, if blood vessels proliferate after vascular stent graft surgery, the blood vessels are prone to blockage again. Therefore, how to reduce the re-blockage rate is also a major issue in vascular stent surgery.
本創作的主要目的在於,提出一種植體,其能吸附更多的藥劑,藉此幫助人體受植體植入的部分復元,或能視情況促進或減緩組織增生。The main purpose of this creation is to propose an implant that can absorb more pharmaceuticals, thereby helping the human body to partially recover from the implant, or to promote or slow down tissue proliferation depending on the situation.
為達上述目的,本創作所提出的植體為血管支架,並具有: 複數個條狀結構;以及 複數個管體,其形成於各該條狀結構上;各該管體形成有一空腔,且各該管體的一端連接於該條狀結構上,另一端形成有一開口,該開口連通於該空腔;該等管體的該另一端的端面共同形成一外表面。 In order to achieve the above purpose, the implant proposed in this creation is a vascular stent and has: A plurality of strip structures; and A plurality of tube bodies are formed on each strip-shaped structure; each tube body forms a cavity, and one end of each tube body is connected to the strip-shaped structure, and the other end forms an opening, and the opening is connected to the strip-shaped structure. Cavity; the end surfaces of the other ends of the tube bodies jointly form an outer surface.
因此,本創作的優點在於,植體的表面形成有許多連通於空腔的開口,因此在植體表面上塗敷藥劑時,藥劑可流入空腔內。由於空腔的最大橫向截面大於開口,因此藥劑可流入空腔後不易由開口流出,而能吸附更多的藥劑。Therefore, the advantage of this invention is that the surface of the implant is formed with many openings connected to the cavity, so when the medicine is applied on the surface of the implant, the medicine can flow into the cavity. Since the maximum transverse cross-section of the cavity is larger than the opening, the medicament can flow into the cavity and not easily flow out through the opening, and more medicament can be adsorbed.
如前所述之植體中,該等空腔的最大橫向截面的面積大於該等開口的截面積,該最大橫向截面平行於該外表面。As mentioned above, in the implant, the maximum transverse cross-sectional area of the cavities is greater than the cross-sectional area of the openings, and the maximum transverse cross-section is parallel to the outer surface.
如前所述之植體更具有複數個通道,其一端分別連通於該等開口,另一端分別連通於該等空腔。The implant as mentioned above further has a plurality of channels, one end of which is connected to the openings, and the other end is connected to the cavities.
如前所述之植體中,該等空腔的縱向截面為圓形、橢圓形、鵝卵形、或三角形,該縱向截面垂直於該外表面。In the implant as mentioned above, the longitudinal sections of the cavities are circular, elliptical, oval, or triangular, and the longitudinal sections are perpendicular to the outer surface.
如前所述之植體中,該等空腔的橫向截面越遠離該外表面而越大,該橫向截面平行於該外表面。As mentioned above, in the implant, the transverse cross-sections of the cavities become larger as they are farther away from the outer surface, and the transverse cross-sections are parallel to the outer surface.
首先請參考圖1及圖3。本創作提出一種植體,其為心導管手術的血管支架A。血管支架A大抵為網狀所構成的管體,圖2中即顯示了血管支架A中構成網狀管的其中一根細絲的一段,而圖3為其截面。血管支架A具有條狀結構101以及每個條狀結構101上都形成有密集的多個管體102。條狀結構101即為前述網狀管的其中一根細絲。First, please refer to Figure 1 and Figure 3. This invention proposes an implant, which is a vascular stent A for cardiac catheterization surgery. The vascular stent A is generally a tube body composed of a mesh. Figure 2 shows a section of one of the filaments forming the mesh tube in the vascular stent A, and Figure 3 is a cross-section thereof. The vascular stent A has a strip structure 101 and a plurality of dense tube bodies 102 formed on each strip structure 101 . The strip structure 101 is one of the filaments of the aforementioned mesh tube.
於本實施例中,各管體102連接於條狀結構101的端部是相鄰接的。管體102內形成有一空腔12,且管體102的一端連接於條狀結構101上,另一端形成有開口11,開口11連通於空腔12。由於管體102呈密集排例,各管體102相對於條狀結構101的端部的端面實質上可共同形成血管支架A的外表面10。如圖3中所,空腔12可為貫穿於管體102的直筒狀空腔,且具體而言空腔12的表面可為平整面,或可具有不規則的凹凸結構。In this embodiment, the ends of each tube body 102 connected to the strip structure 101 are adjacent. A cavity 12 is formed in the tube body 102 , and one end of the tube body 102 is connected to the strip structure 101 , and an opening 11 is formed at the other end, and the opening 11 is connected to the cavity 12 . Since the tube bodies 102 are densely arranged, the end surfaces of each tube body 102 relative to the end of the strip structure 101 can essentially jointly form the outer surface 10 of the vascular stent A. As shown in FIG. 3 , the cavity 12 may be a straight cylindrical cavity penetrating the tube body 102 , and specifically, the surface of the cavity 12 may be a flat surface, or may have an irregular concave-convex structure.
接著請參考圖4至圖7。各個空腔12的縱向截面還可為圓形、橢圓形、鵝卵形、或三角形,而該縱向截面垂直於外表面10。各個空腔12的橫向截面沿著與外表面的距離而有所變化,且橫向截面的最大面積大於所連通的開口11的截面積,而橫向截面平行於外表面10。藉此,使空腔12內有更多空間能吸附藥劑。例如,於圖6及圖7所示的態樣中,空腔12的橫向截面越遠離該外表面10而越大。換言之,於此態樣中空腔12的縱向截面可呈現三角形。Next, please refer to Figure 4 to Figure 7. The longitudinal section of each cavity 12 may also be circular, elliptical, oval, or triangular, with the longitudinal section being perpendicular to the outer surface 10 . The transverse cross-section of each cavity 12 changes along the distance from the outer surface, and the maximum area of the transverse cross-section is larger than the cross-sectional area of the connected opening 11 , and the transverse cross-section is parallel to the outer surface 10 . Thereby, there is more space in the cavity 12 to absorb the medicine. For example, in the aspects shown in FIGS. 6 and 7 , the transverse cross-section of the cavity 12 becomes larger the further away from the outer surface 10 . In other words, in this aspect, the longitudinal cross-section of the cavity 12 may be triangular.
如圖4及圖6所示,管體102內還可選擇性地更具有複數個通道13,空腔12是透過通道13連通於開口11。具體而言,通道13的一端連通於一開口11,另一端連通於一空腔12。本實施例中,一個開口11連通於一個通道13,以及連通於一個空腔12。如圖5及圖7所示,於本實施例中的另一個態樣中,可不具有通道,而是一空腔12直接連通於開口11。As shown in FIGS. 4 and 6 , the tube body 102 may optionally have a plurality of channels 13 , and the cavity 12 is connected to the opening 11 through the channels 13 . Specifically, one end of the channel 13 is connected to an opening 11 , and the other end is connected to a cavity 12 . In this embodiment, an opening 11 is connected to a channel 13 and to a cavity 12 . As shown in FIGS. 5 and 7 , in another aspect of this embodiment, there may be no channel, but a cavity 12 directly connected to the opening 11 .
透過上述結構,植體的表面形成有許多連通於空腔12的開口11,因此在植體表面上塗敷藥劑時,藥劑可流入空腔12內。由於空腔12的最大橫向截面大於開口11,因此藥劑可流入空腔12後不易由開口11流出,而能吸附更多的藥劑。當植體為血管支架A,則藥劑包含了防止血管增生的成份,因此本創作的植體能吸附更多藥劑降低血管增生的情況,達到降低手術後血管的再阻塞率。Through the above structure, many openings 11 connected to the cavity 12 are formed on the surface of the implant. Therefore, when the drug is applied on the surface of the implant, the drug can flow into the cavity 12 . Since the maximum transverse cross-section of the cavity 12 is larger than the opening 11 , the medicine can flow into the cavity 12 and not easily flow out through the opening 11 , and more medicine can be adsorbed. When the implant is vascular stent A, the drug contains ingredients that prevent blood vessel proliferation. Therefore, the implant of this invention can absorb more drugs to reduce blood vessel proliferation, thereby reducing the re-occlusion rate of blood vessels after surgery.
10:外表面 11:開口 12:空腔 13:通道 101:條狀結構 102:管體 A:血管支架 10:Outer surface 11: Open your mouth 12:Cavity 13:Channel 101: Strip structure 102: Pipe body A: Vascular stent
圖1為本創作的立體示意圖。 圖2為本創作的管體的立體示意圖。 圖3為本創作的剖面示意圖。 圖4為本創作的管體的另一態樣的剖面示意圖。 圖5為本創作的管體的另一態樣的剖面示意圖。 圖6為本創作的管體的另一態樣的剖面示意圖。 圖7為本創作的管體的另一態樣的剖面示意圖。 Figure 1 is a three-dimensional schematic diagram of this creation. Figure 2 is a three-dimensional schematic diagram of the tube body of this invention. Figure 3 is a schematic cross-sectional view of this creation. Figure 4 is a schematic cross-sectional view of another aspect of the tube body of this invention. Figure 5 is a schematic cross-sectional view of another aspect of the tube body of this invention. Figure 6 is a schematic cross-sectional view of another aspect of the tube body of this invention. Figure 7 is a schematic cross-sectional view of another aspect of the tube body of this invention.
11:開口 12:空腔 101:條狀結構 102:管體 A: 血管支架 11: Open your mouth 12:Cavity 101: Strip structure 102: Pipe body A: Vascular stent
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW112109422A TWI835590B (en) | 2022-06-06 | 2022-06-06 | Implant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW112109422A TWI835590B (en) | 2022-06-06 | 2022-06-06 | Implant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202406516A TW202406516A (en) | 2024-02-16 |
| TWI835590B true TWI835590B (en) | 2024-03-11 |
Family
ID=90822606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW112109422A TWI835590B (en) | 2022-06-06 | 2022-06-06 | Implant |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI835590B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113974876A (en) * | 2021-11-02 | 2022-01-28 | 广西医科大学 | A drill for a threaded implant |
| CN113974875A (en) * | 2021-11-02 | 2022-01-28 | 广西医科大学 | Porous implant for dentistry |
-
2022
- 2022-06-06 TW TW112109422A patent/TWI835590B/en active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113974876A (en) * | 2021-11-02 | 2022-01-28 | 广西医科大学 | A drill for a threaded implant |
| CN113974875A (en) * | 2021-11-02 | 2022-01-28 | 广西医科大学 | Porous implant for dentistry |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202406516A (en) | 2024-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI813320B (en) | implant | |
| EP1441799B1 (en) | Device for delivering microdoses of agent to the ear | |
| KR20090080534A (en) | Dental implant | |
| ES2304160T3 (en) | INTRAOSE IMPLANT. | |
| US7195646B2 (en) | Polymeric stent useful for the treatment of the salivary gland ducts and method for using the same | |
| KR20110039554A (en) | Small dental implant | |
| CN217488914U (en) | Implant | |
| CN106859791B (en) | A two-stage dental implant | |
| TWI835590B (en) | Implant | |
| TWM634820U (en) | implant | |
| CN115153920A (en) | Implant | |
| US9498305B2 (en) | Endosseous dental implant and abutment for prevention of bone loss | |
| ES2234607T3 (en) | TEAM CONCERNIENT TO THE DEPOSIT OF MEDICATION IN THE MOUTH. | |
| TWM637942U (en) | implant | |
| CN102415925B (en) | Medical cavity duct stent capable of storing medicines | |
| US9662195B2 (en) | Implant device for use in salivary gland duct | |
| TWM538786U (en) | Dental implant | |
| TWI613992B (en) | Osteo-implant | |
| CN207236867U (en) | A kind of two-period form dentistry implant | |
| CN103054653B (en) | Cheek bone implanting device capable of regulating angle randomly | |
| US20200306015A1 (en) | Implant device | |
| CN110575272B (en) | Implant | |
| TWI681760B (en) | Implant device | |
| CN218943550U (en) | Oral implant | |
| CN103083114B (en) | Novel zygoma implant system |